A Randomized, Placebo-controlled Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
Condition: Cardiogenic Shock Interventions: Drug: Istaroxime; Drug: Placebo Sponsors: Windtree Therapeutics; Momentum Research, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials